Tuesday, October 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Divided on Sociedad Quimica Y Minera NYSE SQM Amid Market Shifts

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
TMUS stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Analysts have been sharing their diverse opinions on Sociedad Quimica Y Minera (NYSE: SQM) over the last three months. The consensus rating for SQM stands at “Hold,” as determined by insights from 8 Wall Street analysts. Recent evaluations reveal a breakdown of 6 Buy Ratings, 4 Hold Ratings, and 2 Sell Ratings for SQM, with an average price target of $59.64 during this time period.

Market conditions and company performance have prompted analysts to make adjustments to their ratings and price targets. For instance, Joel Jackson from BMO Capital revised the rating to Outperform, setting a new price target of $70.00. Meanwhile, Corinne Blanchard from Deutsche Bank shifted the rating to Hold with a price target of $48.00. Overall, there has been an 8.33% decrease in the average price target for SQM, indicating a shift towards a more negative sentiment among analysts.

As of March 1, 2024, these changes reflect the evolving landscape surrounding SQM and its potential trajectory in the market.

SQM Stock Price Jumps 3.52% on March 1, 2024: Investors Should Monitor Performance

On March 1, 2024, SQM stock experienced a positive trading day as it saw a 3.52% increase in its share price. The stock opened at $50.94, which was $1.22 higher than its previous close. Throughout the trading day, the price of SQM shares continued to rise, ultimately closing at $52.69, a $1.75 increase from the previous day.

Investors should take note of the recent price increase and monitor SQM’s performance in the coming days to see if this positive trend continues. It will be important to watch for any potential catalysts or news that could impact the stock’s movement.

SQM Stock Declines in Total Revenue and Net Income: Impact on Investors on March 1, 2024

On March 1, 2024, SQM (Sociedad Química y Minera de Chile) stock experienced a decline in its total revenue and net income compared to the previous year and the last quarter. According to data from CNN Money, the total revenue for SQM was $7.47 billion over the past year, which represents a 30.28% decrease from the previous year. In the fourth quarter of the same year, the total revenue further decreased to $1.31 billion, marking a 28.73% decrease from the previous quarter.

Similarly, the net income for SQM was $2.01 billion over the past year, reflecting a 48.48% decrease from the previous year. In the fourth quarter, the net income dropped to $203.20 million, showing a significant 57.61% decrease from the previous quarter.

These declines in total revenue and net income could have had a negative impact on SQM’s stock performance on March 1, 2024. Investors may have reacted to the lower financial results by selling off their shares, leading to a decrease in the stock price.

It is important to note that the earnings per share (EPS) for SQM is currently unavailable, as there is not enough data to create an insight. EPS is a key financial metric that indicates a company’s profitability and is often used by investors to evaluate a stock’s performance.

Overall, the decrease in total revenue and net income for SQM may have contributed to a decline in the stock price on March 1, 2024. Investors should continue to monitor the company’s financial performance and any updates on earnings per share to make informed decisions about their investments in SQM.

Tags: SQM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
financial-data

Expert Opinions on Micron Technology A Diverse Outlook

Market-stocks

Hess CEOs Insider Sale and Company Performance Analysis

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Bearish Options Activity Indicates Investor Sentiment for JDcom

Recommended

Robinhood Stock

Robinhood’s Multi-Front Battle: Legal Challenges and Expansion Efforts

2 months ago
Biomedicine plant based

Cantor Fitzgerald Analyst Maintains Neutral Rating on KLA Corporation

2 years ago
Alphabet Stock

Alphabet’s Regulatory Crossroads: AI Ambitions Clash With Antitrust Threats

2 weeks ago
SNDR stock news

Lakeland Financial Announces Quarterly Dividend and Dividend History

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bellring Brands Shares: Is the Downturn Sustainable?

C3.ai Stock: Navigating a Crossroads of Promise and Peril

MediaAlpha Shares: A Battle Between Conflicting Signals

M&T Bank Shares: Can Strong Fundamentals Overcome Market Weakness?

Opendoor Shares Surge on Cryptocurrency Payment Initiative

ASML Shares Surge as JP Morgan Lifts Price Target Ahead of Earnings

Trending

Gartner Stock
Analysis

Gartner Stock: Institutional Jitters Cloud Recovery Prospects

by Andreas Sommer
October 7, 2025
0

The technology research and advisory firm Gartner finds itself at a critical market juncture. Despite exceeding profit...

Arvinas Stock

Biotech Firm Arvinas Surges on Promising Parkinson’s Treatment Data

October 7, 2025
Harmony Biosciences Holdings Stock

Clinical Trial Failure Sends Harmony Biosciences Shares Plunging

October 7, 2025
Bellring Brands LLC Stock

Bellring Brands Shares: Is the Downturn Sustainable?

October 7, 2025
C3.ai Stock

C3.ai Stock: Navigating a Crossroads of Promise and Peril

October 7, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gartner Stock: Institutional Jitters Cloud Recovery Prospects
  • Biotech Firm Arvinas Surges on Promising Parkinson’s Treatment Data
  • Clinical Trial Failure Sends Harmony Biosciences Shares Plunging

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com